Schmitz, L.; Berdien, B.; Huland, E.; Dase, P.; Beutel, K.; Fisch, M.; Engel, O.
The Impact of a New Interleukin-2-Based Immunotherapy Candidate on Urothelial Cells to Support Use for Intravesical Drug Delivery. Life 2020, 10, 231.
https://doi.org/10.3390/life10100231
AMA Style
Schmitz L, Berdien B, Huland E, Dase P, Beutel K, Fisch M, Engel O.
The Impact of a New Interleukin-2-Based Immunotherapy Candidate on Urothelial Cells to Support Use for Intravesical Drug Delivery. Life. 2020; 10(10):231.
https://doi.org/10.3390/life10100231
Chicago/Turabian Style
Schmitz, Lisa, Belinda Berdien, Edith Huland, Petra Dase, Karin Beutel, Margit Fisch, and Oliver Engel.
2020. "The Impact of a New Interleukin-2-Based Immunotherapy Candidate on Urothelial Cells to Support Use for Intravesical Drug Delivery" Life 10, no. 10: 231.
https://doi.org/10.3390/life10100231
APA Style
Schmitz, L., Berdien, B., Huland, E., Dase, P., Beutel, K., Fisch, M., & Engel, O.
(2020). The Impact of a New Interleukin-2-Based Immunotherapy Candidate on Urothelial Cells to Support Use for Intravesical Drug Delivery. Life, 10(10), 231.
https://doi.org/10.3390/life10100231
